GRI Bio, Inc.
GRI
$1.98
$0.031.54%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 56.78% | -27.85% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 16.15% | -5.05% | |||
| Operating Income | -16.15% | 5.05% | |||
| Income Before Tax | -16.15% | 5.06% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -16.15% | 5.06% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -16.15% | 5.06% | |||
| EBIT | -16.15% | 5.05% | |||
| EBITDA | -16.16% | 5.05% | |||
| EPS Basic | 2.30% | 77.38% | |||
| Normalized Basic EPS | 2.31% | 77.38% | |||
| EPS Diluted | 2.30% | 77.38% | |||
| Normalized Diluted EPS | 2.31% | 77.38% | |||
| Average Basic Shares Outstanding | 18.88% | 319.70% | |||
| Average Diluted Shares Outstanding | 18.88% | 319.70% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||